Edward F. Patz Jr.
James and Alice Chen Distinguished Professor of Radiology
There are numerous ongoing clinical studies primarily focused on the early detection of cancer.
The basic science investigations in our laboratory concentration on three fundamental translational areas,
1) Development of molecular imaging probes - We have used several different approaches to develop novel imaging probes that characterize and phenotype tumors.
2) Discovery of novel lung cancer biomarkers - We explored the use of proteomics, autoantibodies, and genomics to discover blood and tissue biomarkers for early cancer detection and phenotyping of cancer.
3) Host response to cancer - We study the native immune response to tumors as this may provide cues to relevant diagnostic and therapeutic targets. Most recently we have focused on intratumoral lymphocytes and their specific tumor antigens.
Current Appointments & Affiliations
- James and Alice Chen Distinguished Professor of Radiology, Radiology, Cardiothoracic Imaging, Radiology 2004
- Professor of Radiology, Radiology, Cardiothoracic Imaging, Radiology 1999
- Professor in Pathology, Pathology, Clinical Science Departments 2001
- Professor in Pharmacology & Cancer Biology, Pharmacology & Cancer Biology, Basic Science Departments 2002
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1991
Contact Information
- 1515B Hosp North, Durham, NC 27710
- Box 3808 Med Ctr, Durham, NC 27710
-
patz0002@mc.duke.edu
(919) 684-7311
-
http://sites.duke.edu/patzlab/
- Background
-
Education, Training, & Certifications
- Thoracic ImagingFellow, Brigham And Women's Hospital, Harvard University 1989 - 1990
- Resident, Radiology, Brigham And Women's Hospital, Harvard University 1986 - 1990
- Chief Resident in Radiology, Brigham And Women's Hospital, Harvard University 1988 - 1989
- Intern in Medicine, Brigham And Women's Hospital, Brockton West Roxbury Va Medical Center 1984 - 1985
- M.D., University of Maryland School of Medicine 1985
- B.S., Duke University 1980
-
Previous Appointments & Affiliations
- Associate Professor of Radiology with Tenure, Radiology, Cardiothoracic Imaging, Radiology 1997 - 1998
- Associate Professor of Radiology, Radiology, Cardiothoracic Imaging, Radiology 1995 - 1997
- Assistant Professor of Radiology, Radiology, Cardiothoracic Imaging, Radiology 1991 - 1995
- Recognition
-
In the News
-
JUN 17, 2021 Duke Health News -
JUL 3, 2017 Duke Health News -
MAY 8, 2016 Duke Today -
MAY 6, 2016 Fox News -
MAR 16, 2016 -
DEC 10, 2013 USA Today
-
-
Awards & Honors
- Expertise
-
Subject Headings
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Affinity Labels
- Aged
- Aged, 80 and over
- Algorithms
- Amino Acid Sequence
- Analysis of Variance
- Antibodies, Monoclonal
- Antibody Specificity
- Antigens, CD3
- Antigens, Neoplasm
- Antineoplastic Combined Chemotherapy Protocols
- B-Lymphocytes
- Bias
- Binding Sites
- Binding, Competitive
- Biological Markers
- Biological Specimen Banks
- Biopsy
- Biopsy, Needle
- Bleomycin
- Blood Proteins
- Boston
- Brain Neoplasms
- Bronchi
- Bronchiectasis
- Bronchoalveolar Lavage Fluid
- Bronchoscopy
- Calcinosis
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Bronchogenic
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Case-Control Studies
- Cell Growth Processes
- Cell Line
- Chest Tubes
- Chi-Square Distribution
- Child, Preschool
- Clinical Trials as Topic
- Combinatorial Chemistry Techniques
- Combined Modality Therapy
- Conflict of Interest
- Constriction, Pathologic
- Contrast Media
- Costs and Cost Analysis
- Cross Reactions
- Cyclophilin A
- Cyclosporine
- Cystic Adenomatoid Malformation of Lung, Congenital
- Data Interpretation, Statistical
- Deoxyglucose
- Deuterium
- Deuterium Exchange Measurement
- Diabetes Mellitus
- Diagnosis, Computer-Assisted
- Diagnosis, Differential
- Diagnostic Errors
- Diagnostic Imaging
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Doxycycline
- Drainage
- Drug Discovery
- Drug Therapy, Combination
- Early Detection of Cancer
- Early Diagnosis
- Endpoint Determination
- Enzyme-Linked Immunosorbent Assay
- Escherichia coli Proteins
- Ethnic Groups
- Exudates and Transudates
- Feasibility Studies
- Female
- Fibrosis
- Fluorine Radioisotopes
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Forkhead Transcription Factors
- Fractals
- Gene Expression Profiling
- Germinal Center
- Glucose
- Glucose Transporter Type 1
- Glucose Transporter Type 3
- Health Care Costs
- Heart Neoplasms
- Heart Transplantation
- Hematologic Diseases
- Hemoptysis
- Humans
- Hydrogen
- Image Enhancement
- Image Processing, Computer-Assisted
- Immunocompromised Host
- Immunoenzyme Techniques
- Immunohistochemistry
- Immunoprecipitation
- Immunosuppressive Agents
- Incidence
- Infant
- Inflammation
- Insurance, Health, Reimbursement
- International Cooperation
- Iopamidol
- Kidney Transplantation
- Kinetics
- Ligands
- Likelihood Functions
- Lung
- Lung Diseases
- Lung Diseases, Fungal
- Lung Diseases, Interstitial
- Lung Neoplasms
- Lung Transplantation
- Lymph Node Excision
- Lymph Nodes
- Lymphatic Metastasis
- Lymphocytes, Tumor-Infiltrating
- Magnetic Resonance Imaging
- Male
- Mass Screening
- Mass Spectrometry
- Mediastinoscopy
- Mediastinum
- Medicare
- Mesothelioma
- Mice
- Middle Aged
- Models, Biological
- Models, Molecular
- Molecular Imaging
- Molecular Sequence Data
- Monosaccharide Transport Proteins
- Mucormycosis
- Multivariate Analysis
- Muser Mentor
- Mycobacterium Infections, Nontuberculous
- Mycobacterium avium-intracellulare Infection
- Necrosis
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasm, Residual
- Neoplasms
- Nerve Tissue Proteins
- Nontuberculous Mycobacteria
- North Carolina
- Observer Variation
- Organ Transplantation
- Outcome Assessment (Health Care)
- Palliative Care
- Pancreatic Neoplasms
- Paraneoplastic Syndromes
- Patient Selection
- Peptide Fragments
- Peptide Library
- Peptide Mapping
- Peptides
- Pericardium
- Philadelphia
- Phylogeny
- Physician's Practice Patterns
- Pilot Projects
- Piperazines
- Pleura
- Pleural Diseases
- Pleural Effusion
- Pleural Effusion, Malignant
- Pleural Neoplasms
- Pleurodesis
- Pneumonectomy
- Pneumonia, Bacterial
- Pneumonia, Viral
- Pneumothorax
- Polysaccharides
- Positron-Emission Tomography
- Postoperative Complications
- Practice Guidelines as Topic
- Predictive Value of Tests
- Pregnancy Complications
- Pregnancy Complications, Cardiovascular
- Preoperative Care
- Prevalence
- Probability
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Protein Array Analysis
- Protein Binding
- Proteins
- Pulmonary Atelectasis
- Pulmonary Embolism
- Pulmonary Fibrosis
- Pulmonary Veno-Occlusive Disease
- Quality-Adjusted Life Years
- Questionnaires
- ROC Curve
- Radiation Dosage
- Radiation Injuries
- Radiographic Image Enhancement
- Radiography, Interventional
- Radiography, Thoracic
- Radionuclide Imaging
- Radiopharmaceuticals
- Radiotherapy
- Radiotherapy Planning, Computer-Assisted
- Radiotherapy, Computer-Assisted
- Receptor, Epidermal Growth Factor
- Recombinant Proteins
- Registries
- Remission Induction
- Reproducibility of Results
- Research Design
- Retrospective Studies
- Sclerosing Solutions
- Sclerotherapy
- Sensitivity and Specificity
- Sequence Alignment
- Serpins
- Severity of Illness Index
- Smoking
- Societies, Medical
- Solitary Pulmonary Nodule
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Sputum
- Subtraction Technique
- Surface Plasmon Resonance
- Survival Analysis
- Survival Rate
- T-Lymphocytes, Regulatory
- Talc
- Technology, Radiologic
- Thermodynamics
- Thoracic Diseases
- Thoracic Neoplasms
- Thoracoscopy
- Thoracostomy
- Thorax
- Thrombolytic Therapy
- Thymus Gland
- Thymus Hyperplasia
- Time Factors
- Tobacco Industry
- Tomography, Emission-Computed
- Tomography, Spiral Computed
- Tomography, X-Ray Computed
- Treatment Outcome
- Tritium
- Tuberculosis, Pulmonary
- Tumor Cells, Cultured
- Tumor Markers, Biological
- United States
- Validation Studies as Topic
- Variation
- Vascular Diseases
- Video Recording
- Whole-Body Counting
- Research
-
Selected Grants
- Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23) awarded by National Institutes of Health 2023 - 2028
- Synthetic lethality by targeting the core senescent mechanism in lung cancer. awarded by National Institutes of Health 2020 - 2025
- A Novel Immune Modulating Antibody for the Treatment of Lung Cancer awarded by Department of Defense 2019 - 2022
- Organization and Function of Cellular Structure awarded by National Institutes of Health 1975 - 2020
- Pharmacology Industry Internships for Ph.D. Students awarded by American Society for Pharmacology and Experimental Therapeutics 2017 - 2019
- LabCorp-NovellusDX awarded by Laboratory Corporation of America Holdings 2016 - 2019
- Development of a Prognostic Marker for Lung Cancer Using Analysis of Tumor Evolution awarded by Department of Defense 2015 - 2019
- Evaluation of a plasma DNA methylation panel as an aid in diagnosis for lung cancer awarded by Epigenomics AG 2016 - 2018
- Integration of CT imaging features with cell-free plasma DNA as biomarkers for early lung cancer detection in patients with indeterminate pulmonary nodules awarded by Society of Thoracic Radiology 2016 - 2018
- Cancer Biology Training Grant awarded by National Cancer Institute 1993 - 2016
- Clinical Oncology Research Career Development Program awarded by National Institutes of Health 2009 - 2015
- Small Animal PET / CT Molecular Imaging awarded by National Institutes of Health 2011 - 2012
- Discovery of Biomarkers for Lung Cancer Metastasis awarded by National Institutes of Health 2005 - 2010
- Discovery of Cancer Imaging Probes using SUPREX awarded by National Institutes of Health 2008 - 2010
- Serum Biomarkers for Early Diagnosis of NSCLC awarded by Johns Hopkins University 2007 - 2009
- Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers awarded by National Institutes of Health 2002 - 2007
- Molecular Imaging Center Planning Grant awarded by National Institutes of Health 2000 - 2004
- Development of Novel Tumor Imaging Agents awarded by National Institutes of Health 2000 - 2003
- Autologous Bone Marrow Transplantation In Breast And Ovari awarded by National Institutes of Health 1990 - 1997
-
External Relationships
- AstraZeneca
- Bamboo Therapeutics/Pfizer
- Grid Therapeutics, LLC
- LabCorp (Laboratory Corp of America)
- Thermo Fisher Scientific, Inc.
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Han, Dae Hee, Fenghai Duan, and Edward F. Patz. “Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions.” J Thorac Oncol 18, no. 4 (April 2023): e41–42. https://doi.org/10.1016/j.jtho.2023.01.003.Full Text Link to Item
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.” Mol Cancer Ther, March 30, 2023. https://doi.org/10.1158/1535-7163.MCT-22-0723.Full Text Link to Item
-
Chen, Allan S., Hongliang Liu, Yufeng Wu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Mulong Du, David C. Christiani, and Qingyi Wei. “Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.” Mol Carcinog 61, no. 7 (July 2022): 619–28. https://doi.org/10.1002/mc.23400.Full Text Open Access Copy Link to Item
-
Du, Hailei, Rui Mu, Lihua Liu, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, et al. “Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients.” Transl Lung Cancer Res 11, no. 5 (May 2022): 890–901. https://doi.org/10.21037/tlcr-22-104.Full Text Open Access Copy Link to Item
-
Chalian, Hamid, Holman Page McAdams, Youkyung Lee, Fenghai Duan, Yanning Wu, Pegah Khoshpouri, and Edward F. Patz. “Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.” Radiology 302, no. 3 (March 2022): 684–92. https://doi.org/10.1148/radiol.210522.Full Text Link to Item
-
Gottlin, Elizabeth B., Michael J. Campa, Rikesh Gandhi, Ryan T. Bushey, James E. Herndon Nd, and Edward F. Patz. “Prognostic significance of a complement factor H autoantibody in early stage NSCLC.” Cancer Biomark 34, no. 3 (2022): 385–92. https://doi.org/10.3233/CBM-210355.Full Text Open Access Copy Link to Item
-
Kleczko, Emily K., Joanna M. Poczobutt, Andre C. Navarro, Jennifer Laskowski, Amber M. Johnson, Sean P. Korpela, Natalia J. Gurule, et al. “Upregulation of complement proteins in lung cancer cells mediates tumor progression.” Front Oncol 12 (2022): 1045690. https://doi.org/10.3389/fonc.2022.1045690.Full Text Link to Item
-
Mu, Rui, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Mulong Du, David C. Christiani, Lei Jin, and Qingyi Wei. “Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.” Int J Cancer 149, no. 6 (September 15, 2021): 1302–12. https://doi.org/10.1002/ijc.33702.Full Text Open Access Copy Link to Item
-
Han, Dae Hee, Fenghai Duan, Yanning Wu, Jin Mo Goo, Hyae Young Kim, and Edward F. Patz. “Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial.” J Thorac Oncol 16, no. 7 (July 2021): 1118–26. https://doi.org/10.1016/j.jtho.2021.02.025.Full Text Link to Item
-
Bushey, Ryan T., Elizabeth B. Gottlin, Michael J. Campa, and Edward F. Patz. “Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis.” Plos One 16, no. 6 (2021): e0252577. https://doi.org/10.1371/journal.pone.0252577.Full Text Link to Item
-
Chu, Thach H., Edward F. Patz, and Margaret E. Ackerman. “Coming together at the hinges: Therapeutic prospects of IgG3.” Mabs 13, no. 1 (2021): 1882028. https://doi.org/10.1080/19420862.2021.1882028.Full Text Link to Item
-
Du, Hailei, Lihua Liu, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Mulong Du, David C. Christiani, and Qingyi Wei. “Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival.” Am J Cancer Res 11, no. 5 (2021): 2264–77.Open Access Copy Link to Item
-
Li, Xianghan, Yiran Zou, Teng Li, Thomas K. F. Wong, Ryan T. Bushey, Michael J. Campa, Elizabeth B. Gottlin, et al. “Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer.” Front Oncol 11 (2021): 709829. https://doi.org/10.3389/fonc.2021.709829.Full Text Link to Item
-
Liu, Lihua, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Lijuan Lin, David C. Christiani, and Qingyi Wei. “Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival.” Front Oncol 11 (2021): 717109. https://doi.org/10.3389/fonc.2021.717109.Full Text Open Access Copy Link to Item
-
Zhang, Wenfen, Zhenhua Tian, Shujie Yang, Joseph Rich, Shuaiguo Zhao, Mikael Klingeborn, Po-Hsun Huang, et al. “Electrochemical micro-aptasensors for exosome detection based on hybridization chain reaction amplification.” Microsyst Nanoeng 7 (2021): 63. https://doi.org/10.1038/s41378-021-00293-8.Full Text Link to Item
-
Mao, Xiaowen, Longyin Zhou, Sze Keong Tey, Angel Po Yee Ma, Cherlie Lot Sum Yeung, Tung Him Ng, Samuel Wan Ki Wong, et al. “Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.” J Extracell Vesicles 10, no. 1 (November 2020): e12031. https://doi.org/10.1002/jev2.12031.Full Text Link to Item
-
Qian, Danwen, Hongliang Liu, Lingling Zhao, Xiaomeng Wang, Sheng Luo, Patricia G. Moorman, Edward F. Patz, et al. “Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival.” Transl Lung Cancer Res 9, no. 3 (June 2020): 575–86. https://doi.org/10.21037/tlcr-19-318.Full Text Open Access Copy Link to Item
-
Tailor, Tina D., and Edward F. Patz. “Lung Cancer Screening with Chest CT: Efficacy Confirmed.” Radiol Imaging Cancer 2, no. 3 (May 2020): e204015. https://doi.org/10.1148/rycan.2020204015.Full Text Link to Item
-
Liu, Lihua, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Lijuan Lin, David C. Christiani, and Qingyi Wei. “Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.” Am J Cancer Res 10, no. 8 (2020): 2603–16.Open Access Copy Link to Item
-
Tang, Dongfang, Hongliang Liu, Yuchen Zhao, Danwen Qian, Sheng Luo, Edward F. Patz, Li Su, et al. “Genetic variants of BIRC3 and NRG1 in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survival.” Am J Cancer Res 10, no. 8 (2020): 2582–95.Open Access Copy Link to Item
-
Tang, Dongfang, Yu Chen Zhao, Danwen Qian, Hongliang Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, et al. “Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.” Mol Carcinog 59, no. 1 (January 2020): 104–15. https://doi.org/10.1002/mc.23132.Full Text Open Access Copy Link to Item
-
Chen, Ka, Hongliang Liu, Zhensheng Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.” Int J Cancer 145, no. 3 (August 1, 2019): 621–31. https://doi.org/10.1002/ijc.32128.Full Text Open Access Copy Link to Item
-
Qian, Danwen, Hongliang Liu, Xiaomeng Wang, Jie Ge, Sheng Luo, Edward F. Patz, Patricia G. Moorman, et al. “Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.” Int J Cancer 144, no. 8 (April 15, 2019): 1867–76. https://doi.org/10.1002/ijc.31896.Full Text Open Access Copy Link to Item
-
Tailor, Tina D., Xiayu Rao, Michael J. Campa, Jing Wang, Simon G. Gregory, and Edward F. Patz. “Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions.” Front Oncol 9 (2019): 317. https://doi.org/10.3389/fonc.2019.00317.Full Text Link to Item
-
Johnson, David Y., Ryan G. Short, and Edward F. Patz. “Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.” Clin Lung Cancer 19, no. 2 (March 2018): 175–80. https://doi.org/10.1016/j.cllc.2017.10.009.Full Text Link to Item
-
Ashton, Jeffrey R., Elizabeth B. Gottlin, Edward F. Patz, Jennifer L. West, and Cristian T. Badea. “A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.” Plos One 13, no. 11 (2018): e0206950. https://doi.org/10.1371/journal.pone.0206950.Full Text Open Access Copy Link to Item
-
Campa, Michael J., Elizabeth B. Gottlin, James E. Herndon, and Edward F. Patz. “Rethinking Autoantibody Signature Panels for Cancer Diagnosis.” J Thorac Oncol 12, no. 6 (June 2017): 1011–14. https://doi.org/10.1016/j.jtho.2017.01.017.Full Text Link to Item
-
Winkler, Mark T., Ryan T. Bushey, Elizabeth B. Gottlin, Michael J. Campa, Eross S. Guadalupe, Alicia D. Volkheimer, J Brice Weinberg, and Edward F. Patz. “Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.” Plos One 12, no. 6 (2017): e0179841. https://doi.org/10.1371/journal.pone.0179841.Full Text Link to Item
-
Wang, Yu, Sheng-Nan Sun, Qing Liu, Yang-Yang Yu, Jian Guo, Kun Wang, Bao-Cai Xing, et al. “Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.” Cancer Discov 6, no. 9 (September 2016): 1022–35. https://doi.org/10.1158/2159-8290.CD-15-1412.Full Text Link to Item
-
Bushey, Ryan T., M Anthony Moody, Nathan L. Nicely, Barton F. Haynes, S Munir Alam, Stephen T. Keir, Rex C. Bentley, et al. “A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.” Cell Rep 15, no. 7 (May 17, 2016): 1505–13. https://doi.org/10.1016/j.celrep.2016.04.038.Full Text Open Access Copy Link to Item
-
Patz, Edward F., Erin Greco, Constantine Gatsonis, Paul Pinsky, Barnett S. Kramer, and Denise R. Aberle. “Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.” Lancet Oncol 17, no. 5 (May 2016): 590–99. https://doi.org/10.1016/S1470-2045(15)00621-X.Full Text Link to Item
-
Campa, Michael J., M Anthony Moody, Ruijun Zhang, Hua-Xin Liao, Elizabeth B. Gottlin, and Edward F. Patz. “Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.” Cancer Immunol Immunother 65, no. 2 (February 2016): 171–80. https://doi.org/10.1007/s00262-015-1787-0.Full Text Open Access Copy Link to Item
-
Campa, Michael J., Elizabeth B. Gottlin, Ryan T. Bushey, and Edward F. Patz. “Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy.” Cancer Immunol Res 3, no. 12 (December 2015): 1325–32. https://doi.org/10.1158/2326-6066.CIR-15-0122.Full Text Link to Item
-
Paesmans, Marianne, Camilo Garcia, Ching-Yee Oliver Wong, Edward F. Patz, Ritsuko Komaki, Susanne Eschmann, Ramaswamy Govindan, et al. “Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.” Eur Respir J 46, no. 6 (December 2015): 1751–61. https://doi.org/10.1183/13993003.00099-2015.Full Text Link to Item
-
Kwon, Woocheol, Brandon A. Howard, James E. Herndon, and Edward F. Patz. “Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".” J Thorac Oncol 10, no. 10 (October 2015): e102. https://doi.org/10.1097/JTO.0000000000000637.Full Text Open Access Copy Link to Item
-
Kwon, Woocheol, Brandon A. Howard, James E. Herndon, and Edward F. Patz. “FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.” J Thorac Oncol 10, no. 6 (June 2015): 897–902. https://doi.org/10.1097/JTO.0000000000000534.Full Text Link to Item
-
Pinsky, Paul F., David S. Gierada, William Hocking, Edward F. Patz, and Barnett S. Kramer. “National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.” Ann Intern Med 161, no. 9 (November 4, 2014): 627–33. https://doi.org/10.7326/M14-1484.Full Text Link to Item
-
Boiselle, Phillip M., Caroline Chiles, Edward Patz, Martin Tammemägi, and Douglas E. Wood. “Expert opinion: United States Preventive Services Task Force recommendation on screening for lung cancer.” J Thorac Imaging 29, no. 4 (July 2014): 197. https://doi.org/10.1097/RTI.0000000000000094.Full Text Link to Item
-
Patz, Edward F., Paul Pinsky, and Barnett S. Kramer. “Estimating overdiagnosis in lung cancer screening--reply.” Jama Intern Med 174, no. 7 (July 2014): 1198–99. https://doi.org/10.1001/jamainternmed.2014.1525.Full Text Link to Item
-
Patz, Edward F. “Conflict of interest disclosures.” Jama Intern Med 174, no. 5 (May 2014): 823. https://doi.org/10.1001/jamainternmed.2014.758.Full Text Link to Item
-
“Missing Conflict of Interest Disclosures.” Jama Internal Medicine 174, no. 5 (May 1, 2014): 828–828. https://doi.org/10.1001/jamainternmed.2014.1137.Full Text
-
Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.” J Thorac Oncol 9, no. 4 (April 2014): 512–18. https://doi.org/10.1097/JTO.0000000000000102.Full Text Link to Item
-
Erasmus, Jeremy J., Osama Mawlawi, Brandon Howard, and Edward F. Patz. “PET-CT: current applications and new developments in the thorax.” Semin Respir Crit Care Med 35, no. 1 (February 2014): 145–56. https://doi.org/10.1055/s-0033-1363459.Full Text Link to Item
-
Patz, Edward F., Paul Pinsky, Constantine Gatsonis, Jorean D. Sicks, Barnett S. Kramer, Martin C. Tammemägi, Caroline Chiles, William C. Black, Denise R. Aberle, and Denise R. NLST Overdiagnosis Manuscript Writing Team. “Overdiagnosis in low-dose computed tomography screening for lung cancer.” Jama Intern Med 174, no. 2 (February 1, 2014): 269–74. https://doi.org/10.1001/jamainternmed.2013.12738.Full Text Link to Item
-
Patz, Edward F., Michael J. Campa, Elizabeth B. Gottlin, Priscilla R. Trotter, James E. Herndon, Don Kafader, Russell P. Grant, and Marcia Eisenberg. “Biomarkers to help guide management of patients with pulmonary nodules.” Am J Respir Crit Care Med 188, no. 4 (August 15, 2013): 461–65. https://doi.org/10.1164/rccm.201210-1760OC.Full Text Open Access Copy Link to Item
-
Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007.” Radiology 267, no. 3 (June 2013): 807–17. https://doi.org/10.1148/radiol.12120174.Full Text Link to Item
-
Dinan, Michaela A., William R. Carpenter, Edward F. Patz, Amy P. Abernethy, Andrea K. Biddle, Kevin A. Schulman, and Lesley H. Curtis. “Reply to M.S. Hofman et al.” J Clin Oncol 31, no. 6 (February 20, 2013): 820. https://doi.org/10.1200/JCO.2012.46.7373.Full Text Link to Item
-
Boyce, Sarah J., H Page McAdams, Carl E. Ravin, Edward F. Patz, Lacey Washington, Santiago Martinez, Lynne Koweek, and Ehsan Samei. “Preliminary evaluation of biplane correlation (BCI) stereographic imaging for lung nodule detection.” J Digit Imaging 26, no. 1 (February 2013): 109–14. https://doi.org/10.1007/s10278-012-9466-6.Full Text Link to Item
-
Boiselle, Phillip M., Jeremy J. Erasmus, Hans-Ulrich Kauczor, King Li, and Edward Patz. “Expert opinion: the future role of cardiothoracic radiologists in molecular imaging.” J Thorac Imaging 28, no. 1 (January 2013): 2. https://doi.org/10.1097/RTI.0b013e31827b0fa7.Full Text Link to Item
-
Christensen, Jared D., and Edward F. Patz. “Future trends in lung cancer diagnosis.” Radiol Clin North Am 50, no. 5 (September 2012): 1001–8. https://doi.org/10.1016/j.rcl.2012.06.002.Full Text Link to Item
-
Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.” J Clin Oncol 30, no. 22 (August 1, 2012): 2725–30. https://doi.org/10.1200/JCO.2011.40.4392.Full Text Link to Item
-
Roberts, Andrew S., Michael J. Campa, Elizabeth B. Gottlin, Chen Jiang, Kouros Owzar, Hedy L. Kindler, Alan P. Venook, Richard M. Goldberg, Eileen M. O’Reilly, and Edward F. Patz. “Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303).” Cancer 118, no. 2 (January 15, 2012): 571–78. https://doi.org/10.1002/cncr.26270.Full Text Link to Item
-
Gottlin, Elizabeth B., Rex C. Bentley, Michael J. Campa, David S. Pisetsky, James E. Herndon, and Edward F. Patz. “The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancer.” J Thorac Oncol 6, no. 10 (October 2011): 1687–90. https://doi.org/10.1097/JTO.0b013e3182217bec.Full Text Link to Item
-
National Lung Screening Trial Research Team, Carl J., Denise R. Aberle, Christine D. Berg, William C. Black, Timothy R. Church, Richard M. Fagerstrom, Barbara Galen, et al. “The National Lung Screening Trial: overview and study design.” Radiology 258, no. 1 (January 2011): 243–53. https://doi.org/10.1148/radiol.10091808.Full Text Link to Item
-
Auffermann, W. F., L. Washington, E. B. Gottlin, and E. F. Patz. “The role of biomarkers in thoracic imaging.” Imaging in Medicine 2, no. 5 (October 1, 2010): 575–81. https://doi.org/10.2217/iim.10.47.Full Text
-
Dearmond, Patrick D., Graham M. West, Victor Anbalagan, Michael J. Campa, Edward F. Patz, and Michael C. Fitzgerald. “Discovery of novel cyclophilin A ligands using an H/D exchange- and mass spectrometry-based strategy.” J Biomol Screen 15, no. 9 (October 2010): 1051–62. https://doi.org/10.1177/1087057110382775.Full Text Link to Item
-
Patz, Edward F., Neil E. Caporaso, Steven M. Dubinett, Pierre P. Massion, Fred R. Hirsch, John D. Minna, Constantine Gatsonis, et al. “National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.” J Thorac Oncol 5, no. 10 (October 2010): 1502–6. https://doi.org/10.1097/JTO.0b013e3181f1c634.Full Text Link to Item
-
Christensen, Jared D., Tom V. Colby, and Edward F. Patz. “Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.” Cancer 116, no. 17 (September 1, 2010): 4095–4102. https://doi.org/10.1002/cncr.25302.Full Text Link to Item
-
Amornsiripanitch, Nita, Shaolin Hong, Michael J. Campa, Michael M. Frank, Elizabeth B. Gottlin, and Edward F. Patz. “Complement factor H autoantibodies are associated with early stage NSCLC.” Clin Cancer Res 16, no. 12 (June 15, 2010): 3226–31. https://doi.org/10.1158/1078-0432.CCR-10-0321.Full Text Link to Item
-
Dinan, Michaela A., Lesley H. Curtis, Bradley G. Hammill, Edward F. Patz, Amy P. Abernethy, Alisa M. Shea, and Kevin A. Schulman. “Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.” Jama 303, no. 16 (April 28, 2010): 1625–31. https://doi.org/10.1001/jama.2010.460.Full Text Link to Item
-
Hansell, David M., Phillip M. Boiselle, Jonathan Goldin, Hans-Ulrik Kauczor, David A. Lynch, John R. Mayo, and Edward F. Patz. “Thoracic imaging.” Respirology 15, no. 3 (April 2010): 393–400. https://doi.org/10.1111/j.1440-1843.2009.01698.x.Full Text Link to Item
-
Birchard, K. R., and E. E. Patz. “Reply to early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.” Cancer 116, no. 6 (March 15, 2010): 1616. https://doi.org/10.1002/cncr.24806.Full Text
-
Patz, Edward F., and Jeremy J. Erasmus. “Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.” J Thorac Imaging 25, no. 1 (February 2010): 39–40. https://doi.org/10.1097/RTI.0b013e3181caa973.Full Text Link to Item
-
Patz, Jr Edward F. “Implementation of IASLC revised staging system: imaging implications.” Journal of Thoracic Oncology 4, no. 9 (September 1, 2009): S16–17.Link to Item
-
Hopper, Erin D., Adrianne M. C. Pittman, Chandra L. Tucker, Michael J. Campa, Edward F. Patz, and Michael C. Fitzgerald. “Hydrogen/deuterium exchange- and protease digestion-based screening assay for protein-ligand binding detection.” Anal Chem 81, no. 16 (August 15, 2009): 6860–67. https://doi.org/10.1021/ac900854t.Full Text Link to Item
-
Birchard, Katherine R., Jenny K. Hoang, James E. Herndon, and Edward F. Patz. “Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.” Cancer 115, no. 3 (February 1, 2009): 581–86. https://doi.org/10.1002/cncr.24060.Full Text Link to Item
-
Gottlin, Elizabeth B., Elizabeth B. Xiangrong Guan, Charles Pegram, Allen Cannedy, Michael J. Campa, and Edward F. Patz. “Isolation of novel EGFR-specific VHH domains.” J Biomol Screen 14, no. 1 (January 2009): 77–85. https://doi.org/10.1177/1087057108327064.Full Text Link to Item
-
Patz, Edward F. “Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?” J Clin Oncol 26, no. 28 (October 1, 2008): 4542–43. https://doi.org/10.1200/JCO.2008.18.2147.Full Text Link to Item
-
Hopper, Erin D., Petra L. Roulhac, Michael J. Campa, Edward F. Patz, and Michael C. Fitzgerald. “Throughput and efficiency of a mass spectrometry-based screening assay for protein-ligand binding detection.” J Am Soc Mass Spectrom 19, no. 9 (September 2008): 1303–11. https://doi.org/10.1016/j.jasms.2008.06.007.Full Text Link to Item
-
Schultz, E. M., G. D. Sanders, P. R. Trotter, E. F. Patz, G. A. Silvestri, D. K. Owens, and M. K. Gould. “Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.” Thorax 63, no. 4 (April 2008): 335–41. https://doi.org/10.1136/thx.2007.084731.Full Text Link to Item
-
Hoang, Jenny K., Luke F. Hoagland, R Edward Coleman, April D. Coan, James E. Herndon, and Edward F. Patz. “Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.” J Clin Oncol 26, no. 9 (March 20, 2008): 1459–64. https://doi.org/10.1200/JCO.2007.14.3628.Full Text Link to Item
-
Berghmans, Thierry, Michèle Dusart, Marianne Paesmans, Claude Hossein-Foucher, Irene Buvat, Catherine Castaigne, Arnaud Scherpereel, et al. “Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.” J Thorac Oncol 3, no. 1 (January 2008): 6–12. https://doi.org/10.1097/JTO.0b013e31815e6d6b.Full Text Link to Item
-
Patz, Edward F., Michael J. Campa, Elizabeth B. Gottlin, Irina Kusmartseva, Xiang Rong Guan, and James E. Herndon. “Panel of serum biomarkers for the diagnosis of lung cancer.” J Clin Oncol 25, no. 35 (December 10, 2007): 5578–83. https://doi.org/10.1200/JCO.2007.13.5392.Full Text Link to Item
-
Hoang, Jenny K., Edward Patz, Dorothy Giroux, and Peter Goldstraw. “Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.” J Thorac Oncol 2, no. 12 (December 2007): 1103–6. https://doi.org/10.1097/JTO.0b013e31815c04b4.Full Text Link to Item
-
Hoagland, Luke F. M., Michael J. Campa, Elizabeth B. Gottlin, James E. Herndon, and Edward F. Patz. “Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.” Cancer 110, no. 10 (November 15, 2007): 2260–68. https://doi.org/10.1002/cncr.23049.Full Text Link to Item
-
Postmus, Pieter E., Elisabeth Brambilla, Kari Chansky, John Crowley, Peter Goldstraw, Edward F. Patz, Hiroyasu Yokomise, et al. “The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.” J Thorac Oncol 2, no. 8 (August 2007): 686–93. https://doi.org/10.1097/JTO.0b013e31811f4703.Full Text Link to Item
-
Gauger, Joerg, Edward F. Patz, R Edward Coleman, and James E. Herndon. “Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.” J Thorac Oncol 2, no. 6 (June 2007): 499–505. https://doi.org/10.1097/JTO.0b013e3180600990.Full Text Link to Item
-
Wong, Terence Z., Erik K. Paulson, Rendon C. Nelson, Edward F. Patz, and R Edward Coleman. “Practical approach to diagnostic CT combined with PET.” Ajr Am J Roentgenol 188, no. 3 (March 2007): 622–29. https://doi.org/10.2214/AJR.06.0813.Full Text Link to Item
-
Gandara, D. R., D. Aberle, D. Lau, J. Jett, T. Akhurst, R. Heelan, J. Mulshine, C. Berg, and E. F. Patz. “Erratum: Radiographic imaging of bronchioloalveolar carcinoma: Screening, patterns of presentation and response assessment (Journal of Thoracic Oncology (2006) 1, (S20-S26)).” Journal of Thoracic Oncology 2, no. 1 (January 1, 2007): 11.
-
Gandara, D. R., D. Aberle, D. Lau, J. Jett, T. Akhurst, R. Heelan, J. Mulshine, C. Berg, and E. F. Patz. “Radiographic imaging of bronchioloalveolar carcinoma: Screening, patterns of presentation and response assessment (vol 1, pg S 20, 2006).” Journal of Thoracic Oncology 2, no. 1 (January 1, 2007): 11–11.Link to Item
-
Petersen, Rebecca P., Michael J. Campa, Justin Sperlazza, Debbi Conlon, Mary-Beth Joshi, David H. Harpole, and Edward F. Patz. “Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.” Cancer 107, no. 12 (December 15, 2006): 2866–72. https://doi.org/10.1002/cncr.22282.Full Text Link to Item
-
Lin, S., S. Mungal, R. Haney, E. F. Patz, and P. Mcconnell. “Proteomics with mass spectrometry,” December 1, 2006, 85–103. https://doi.org/10.4018/978-1-59140-863-5.ch005.Full Text
-
Gandara, David R., Denise Aberle, Derick Lau, James Jett, Tim Akhurst, Robert Heelan, James Mulshine, Christine Berg, and Edward F. Patz. “Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.” J Thorac Oncol 1, no. 9 Suppl (November 2006): S20–26.Link to Item
-
Patz, Edward F. “Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project.” J Natl Cancer Inst 98, no. 11 (June 7, 2006): 724–25. https://doi.org/10.1093/jnci/djj226.Full Text Link to Item
-
Gandara, D. R., D. Aberle, D. Lau, J. Jett, T. Akhurst, J. Mulshine, C. Berg, and E. F. Patz. “Radiographic imaging of bronchioloalveolar carcinoma: Screening, patterns of presentation and response assessment.” Journal of Thoracic Oncology 1, no. 9 SUPPL. (January 1, 2006). https://doi.org/10.1016/s1556-0864(15)30005-8.Full Text
-
Patz, Edward F. “Integration of biomarkers and imaging.” J Thorac Oncol 1, no. 1 (January 2006): 78–80.Link to Item
-
Patz, E. F., S. J. Swensen, and J. E. Herndon. “In reply [4].” Journal of Clinical Oncology 23, no. 9 (December 1, 2005): 2107–8. https://doi.org/10.1200/JCO.2005.05.267.Full Text
-
Patz, E. F., S. J. Swensen, and J. E. Herndon. “In reply [12].” Journal of Clinical Oncology 23, no. 10 (December 1, 2005): 2440–41. https://doi.org/10.1200/JCO.2005.05.230.Full Text
-
Swensen, S., D. Aberle, E. A. Kazerooni, D. Naidich, N. Patz, J. R. Galvin, and C. I. Henschke. “Consensus statement: CT screening for lung cancer.” Journal of Thoracic Imaging 20, no. 4 (November 1, 2005): 321. https://doi.org/10.1097/01.rti.0000187437.37256.18.Full Text
-
MacMahon, Heber, John H. M. Austin, Gordon Gamsu, Christian J. Herold, James R. Jett, David P. Naidich, Edward F. Patz, Stephen J. Swensen, and Stephen J. Fleischner Society. “Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.” Radiology 237, no. 2 (November 2005): 395–400. https://doi.org/10.1148/radiol.2372041887.Full Text Link to Item
-
Howard, Brandon A., Ryohei Furumai, Michael J. Campa, Zahid N. Rabbani, Zeljko Vujaskovic, Xiao-Fan Wang, and Edward F. Patz. “Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo.” Cancer Res 65, no. 19 (October 1, 2005): 8853–60. https://doi.org/10.1158/0008-5472.CAN-05-1219.Full Text Link to Item
-
Lin, Simon M., Richard P. Haney, Michael J. Campa, Michael C. Fitzgerald, and Edward F. Patz. “Characterising phase variations in MALDI-TOF data and correcting them by peak alignment.” Cancer Inform 1, no. 1 (2005): 32–40.Open Access Copy Link to Item
-
Patz, E. “Using phage peptides to detect protein differences between cancer and normal tissues.” Cancer Biology and Therapy 3, no. 12 (December 1, 2004): 1194–95.
-
Howard, Brandon A., Zhong Zheng, Michael J. Campa, Michael Z. Wang, Anupama Sharma, Eric Haura, James E. Herndon, Michael C. Fitzgerald, Gerold Bepler, and Edward F. Patz. “Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.” Lung Cancer 46, no. 3 (December 2004): 313–23. https://doi.org/10.1016/j.lungcan.2004.05.013.Full Text Link to Item
-
Suber, R Lee, Vincent L. Flanders, Michael J. Campa, and Edward F. Patz. “Accentuation of differentially expressed proteins using phage technology.” Anal Biochem 333, no. 2 (October 15, 2004): 351–57. https://doi.org/10.1016/j.ab.2004.06.029.Full Text Link to Item
-
Wang, Michael Z., Jagat T. Shetty, Brandon A. Howard, Michael J. Campa, Edward F. Patz, and Michael C. Fitzgerald. “Thermodynamic analysis of cyclosporin a binding to cyclophilin a in a lung tumor tissue lysate.” Anal Chem 76, no. 15 (August 1, 2004): 4343–48. https://doi.org/10.1021/ac049536j.Full Text Link to Item
-
Khan, Nayela, Charles J. Cromer, Michael Campa, and Edward F. Patz. “Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.” Cancer 101, no. 2 (July 15, 2004): 379–84. https://doi.org/10.1002/cncr.20377.Full Text Link to Item
-
Cheran, Sendhil Kumar, James E. Herndon, and Edward F. Patz. “Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.” Lung Cancer 44, no. 3 (June 2004): 317–25. https://doi.org/10.1016/j.lungcan.2003.11.008.Full Text Link to Item
-
Patz, Edward F., Stephen J. Swensen, and James E. Herndon. “Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.” J Clin Oncol 22, no. 11 (June 1, 2004): 2202–6. https://doi.org/10.1200/JCO.2004.12.046.Full Text Link to Item
-
Cheran, Sendhil Kumar, Nathan D. Nielsen, and Edward F. Patz. “False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications.” Ajr Am J Roentgenol 182, no. 5 (May 2004): 1129–32. https://doi.org/10.2214/ajr.182.5.1821129.Full Text Link to Item
-
Campa, M. J., M. C. Fitzgerald, and E. F. Patz. “Erratum: Exploring the proteome with MALDI-TOF (Editorial) (Proteomics 3: 9 (1659-1660)).” Proteomics 3, no. 10 (October 1, 2003): 2067. https://doi.org/10.1002/pmic.200390099.Full Text
-
Campa, M. J., M. C. Fitzgerald, and E. F. Patz. “Exploring the proteome with MALDI-TOF (editorial) (vol 3, pg 1659, 2003).” Proteomics 3, no. 10 (October 1, 2003): 2067–2067.Link to Item
-
Campa, M. J., M. C. Fitzgerald, and E. F. Patz. “Exploring the proteome with MALDI-TOF.” Proteomics 3, no. 9 (September 1, 2003): 1659–60.
-
Grannis, Frederic W. “Conflict of interest.” Am J Respir Crit Care Med 168, no. 5 (September 1, 2003): 613. https://doi.org/10.1164/ajrccm.168.5.952.Full Text Link to Item
-
Howard, Brandon A., Michael Z. Wang, Michael J. Campa, Christina Corro, Michael C. Fitzgerald, and Edward F. Patz. “Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.” Proteomics 3, no. 9 (September 2003): 1720–24. https://doi.org/10.1002/pmic.200300514.Full Text Link to Item
-
Wang, Michael Z., Brandon Howard, Michael J. Campa, Edward F. Patz, and Michael C. Fitzgerald. “Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry.” Proteomics 3, no. 9 (September 2003): 1661–66. https://doi.org/10.1002/pmic.200300513.Full Text Link to Item
-
Campa, Michael J., Michael Z. Wang, Brandon Howard, Michael C. Fitzgerald, and Edward F. Patz. “Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.” Cancer Res 63, no. 7 (April 1, 2003): 1652–56.Link to Item
-
Patz, E. F., and P. C. Goodman. “Conflict of interest.” American Journal of Respiratory and Critical Care Medicine 168, no. 5 (2003): 613–613.Link to Item
-
Patz, E. F., and P. C. Goodman. “Potential conflict of interest in AJRCCM.” American Journal of Respiratory and Critical Care Medicine 166, no. 12 (December 15, 2002): 1608–1608.Link to Item
-
Grannis, Frederic W. “Potential conflict of interest in AJRCCM.” Am J Respir Crit Care Med 166, no. 12 Pt 1 (December 15, 2002): 1608. https://doi.org/10.1164/ajrccm.166.12.251c.Full Text Link to Item
-
Wang, M. Z., M. Campa, B. A. Howard, E. F. Patz, and M. C. Fitzgerald. “A fractionation protocol to reduce signal suppression effects in the MALDI analysis of blood proteins.” Proceedings 50th Asms Conference on Mass Spectrometry and Allied Topics, December 1, 2002, 587–88.
-
Heyneman, Laura E., and Edward F. Patz. “PET imaging in patients with bronchioloalveolar cell carcinoma.” Lung Cancer 38, no. 3 (December 2002): 261–66. https://doi.org/10.1016/s0169-5002(02)00221-0.Full Text Link to Item
-
Patz, E. F., W. C. Black, and P. C. Goodman. “Screening for lung cancer: Been there and done that - Response.” Radiology 224, no. 3 (September 1, 2002): 928–29.Link to Item
-
Patz, E. F., W. C. Black, and P. C. Goodman. “Mortality rate and screening - Response.” Radiology 224, no. 3 (September 1, 2002): 929–30.Link to Item
-
Añorbe, Enrique, and Pilar Aisa. “Mortality rate and screening.” Radiology 224, no. 3 (September 2002): 929. https://doi.org/10.1148/radiol.2243020005.Full Text Link to Item
-
Hall, Ferris M. “Screening for lung cancer: been there and done that.” Radiology 224, no. 3 (September 2002): 928. https://doi.org/10.1148/radiol.2243012121.Full Text Link to Item
-
Campa, Michael J., Scott B. Serlin, and Edward F. Patz. “Development of novel tumor imaging agents with phage-display combinatorial peptide libraries.” Acad Radiol 9, no. 8 (August 2002): 927–32. https://doi.org/10.1016/s1076-6332(03)80463-4.Full Text Link to Item
-
Marom, Edith M., Sarah Sarvis, James E. Herndon, and Edward F. Patz. “T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.” Radiology 223, no. 2 (May 2002): 453–59. https://doi.org/10.1148/radiol.2232011131.Full Text Link to Item
-
Marom, Edith M., Jeremy J. Erasmus, Harvey I. Pass, and Edward F. Patz. “The role of imaging in malignant pleural mesothelioma.” Semin Oncol 29, no. 1 (February 2002): 26–35. https://doi.org/10.1053/sonc.2002.30228.Full Text Link to Item
-
Heyneman, L. E., J. E. Herndon, P. C. Goodman, and E. F. Patz. “Stage distribution in patients with a small (< or = 3 cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening.” Cancer 92, no. 12 (December 15, 2001): 3051–55. https://doi.org/10.1002/1097-0142(20011215)92:12<3051::aid-cncr10106>3.0.co;2-s.Full Text Link to Item
-
Heyneman, L. E., J. E. Herndon, P. C. Goodman, and E. F. Patz. “Stage distribution in patients with a small (.” Cancer 92, no. 12 (December 2001): 3051–55.
-
Patz, E. F., W. C. Black, and P. C. Goodman. “CT screening for lung cancer: not ready for routine practice.” Radiology 221, no. 3 (December 2001): 587–91. https://doi.org/10.1148/radiol.2213001643.Full Text Link to Item
-
Marom, E. M., S. Sarvis, J. E. Herndon, and E. F. Patz. “Accuracy of positron emission tomography with fluorodeoxyglucose in T1 lung cancer.” Radiology 221 (November 1, 2001): 408–408.Link to Item
-
Dammas, S., E. F. Patz, and P. C. Goodman. “Identification of small lung nodules at autopsy: implications for lung cancer screening and overdiagnosis bias.” Lung Cancer 33, no. 1 (July 2001): 11–16. https://doi.org/10.1016/s0169-5002(01)00190-8.Full Text Link to Item
-
Crotty, E., and E. F. Patz. “FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer.” J Thorac Imaging 16, no. 2 (April 2001): 89–93. https://doi.org/10.1097/00005382-200104000-00004.Full Text Link to Item
-
Miettinen, O. S., D. F. Yankelevitz, and C. I. Henschke. “Screening for lung cancer.” N Engl J Med 344, no. 12 (March 22, 2001): 935.Link to Item
-
Patz, E. F., P. C. Goodman, and G. Bepler. “Screening for lung cancer. Reply.” New England Journal of Medicine 344, no. 12 (March 22, 2001): 936–936.Link to Item
-
Mulshine, J. L., and R. W. Day. “Screening for lung cancer.” N Engl J Med 344, no. 12 (March 22, 2001): 935–36. https://doi.org/10.1056/NEJM200103223441213.Full Text Link to Item
-
Patz, E. F., and P. C. Goodman. “Low-dose spiral computed tomography screening for lung cancer: not ready for prime time.” Am J Respir Crit Care Med 163, no. 4 (March 2001): 813–14. https://doi.org/10.1164/ajrccm.163.4.16342b.Full Text Link to Item
-
Baumann, M. H., C. Strange, J. E. Heffner, R. Light, T. J. Kirby, J. Klein, J. D. Luketich, E. A. Panacek, S. A. Sahn, and S. A. AACP Pneumothorax Consensus Group. “Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement.” Chest 119, no. 2 (February 2001): 590–602. https://doi.org/10.1378/chest.119.2.590.Full Text Link to Item
-
Patz, J., W. C. Black, and P. C. Goodman. “Commentary on Drs Miettinen and Henschke's viewpoint.” Radiology 221, no. 3 (January 1, 2001): 597. https://doi.org/10.1148/radiol.2213010618.Full Text
-
Aloia, T., G. Bepler, D. Harpole, P. C. Goodman, H. P. McAdams, J. J. Erasmus, J. E. Herndon, and E. F. Patz. “Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities.” Cancer Detect Prev 25, no. 4 (2001): 336–43.Link to Item
-
Crocetti, E., and E. Paci. “Stage IA non-small cell lung cancer: a small proportion of cases in the general population.” Chest 119, no. 1 (January 2001): 313–15. https://doi.org/10.1378/chest.119.1.313.Full Text Link to Item
-
Marom, E. M., T. A. Aloia, M. B. Moore, M. Hara, J. E. Herndon, D. H. Harpole, P. C. Goodman, and E. F. Patz. “Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.” Lung Cancer 33, no. 2–3 (2001): 99–107. https://doi.org/10.1016/s0169-5002(00)00250-6.Full Text Link to Item
-
Patz, Edward F., and Philip C. Goodman. “Stage IA Non-small Cell Lung Cancer A Small Proportion of Cases in the General Population.” Chest 119, no. 1 (January 2001): 314–15. https://doi.org/10.1016/s0012-3692(15)37614-5.Full Text
-
Patz, E. F., P. C. Goodman, and G. Bepler. “Screening for lung cancer.” N Engl J Med 343, no. 22 (November 30, 2000): 1627–33. https://doi.org/10.1056/NEJM200011303432208.Full Text Link to Item
-
Lau, C. L., D. H. Harpole, and E. Patz. “Staging techniques for lung cancer.” Chest Surg Clin N Am 10, no. 4 (November 2000): 781–801.Link to Item
-
Campa, M. J., C. T. Kuan, M. D. O’Connor-McCourt, D. D. Bigner, and E. F. Patz. “Design of a novel small peptide targeted against a tumor-specific receptor.” Biochem Biophys Res Commun 275, no. 2 (August 28, 2000): 631–36. https://doi.org/10.1006/bbrc.2000.3347.Full Text Link to Item
-
Erasmus, J. J., H. P. McAdams, S. E. Rossi, P. C. Goodman, R. E. Coleman, and E. F. Patz. “FDG PET of pleural effusions in patients with non-small cell lung cancer.” Ajr Am J Roentgenol 175, no. 1 (July 2000): 245–49. https://doi.org/10.2214/ajr.175.1.1750245.Full Text Link to Item
-
Black, W. C. “Unexpected observations on tumor size and survival in stage IA non-small cell lung cancer.” Chest 117, no. 6 (June 2000): 1532–34. https://doi.org/10.1378/chest.117.6.1532.Full Text Link to Item
-
Farrell, M. A., H. P. McAdams, J. E. Herndon, and E. F. Patz. “Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.” Radiology 215, no. 3 (June 2000): 886–90. https://doi.org/10.1148/radiology.215.3.r00jn29886.Full Text Link to Item
-
Marom, E. M., J. J. Erasmus, and E. F. Patz. “Lung cancer and positron emission tomography with fluorodeoxyglucose.” Lung Cancer 28, no. 3 (June 2000): 187–202. https://doi.org/10.1016/s0169-5002(00)00096-9.Full Text Link to Item
-
Patz, E. F., S. Rossi, D. H. Harpole, J. E. Herndon, and P. C. Goodman. “Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer.” Chest 117, no. 6 (June 2000): 1568–71. https://doi.org/10.1378/chest.117.6.1568.Full Text Link to Item
-
Patz, E. F. “Imaging bronchogenic carcinoma.” Chest 117, no. 4 Suppl 1 (April 2000): 90S-95S. https://doi.org/10.1378/chest.117.4_suppl_1.90s.Full Text Link to Item
-
Erasmus, J. J., P. C. Goodman, and E. F. Patz. “Management of malignant pleural effusions and pneumothorax.” Radiol Clin North Am 38, no. 2 (March 2000): 375–83. https://doi.org/10.1016/s0033-8389(05)70168-8.Full Text Link to Item
-
Patz, E. F., J. Connolly, and J. Herndon. “Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer.” Ajr Am J Roentgenol 174, no. 3 (March 2000): 769–74. https://doi.org/10.2214/ajr.174.3.1740769.Full Text Link to Item
-
Patz, E. F. “From the guest editor.” Journal of Thoracic Imaging 15, no. 1 (January 13, 2000): 2. https://doi.org/10.1097/00005382-200001000-00002.Full Text
-
Kitase, M., M. Hara, K. Katoh, Y. Satoh, M. Satake, H. Miyagawa, H. Ogino, M. Itoh, S. Ohba, and J. Patz. “FDG-PET in patient with clinical T1N0 lung cancer; Determination of nodal status.” Japanese Journal of Clinical Radiology 45, no. 1 (January 1, 2000): 209–14.
-
Nakayama, J., M. Hara, N. Miura, T. Sugie, M. Satake, H. Tomita, M. Kitase, H. Ogino, S. Ohba, and J. Patz. “Clinical T1 lung cancer; evaluation with FDG-PET.” Japanese Journal of Clinical Radiology 45, no. 1 (January 1, 2000): 215–19.
-
Patz, E. F. “1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.” Radiographics 20, no. 4 (2000): 1182–85. https://doi.org/10.1148/radiographics.20.4.g00jl171182.Full Text Link to Item
-
Swensen, S. J., K. Yamashita, C. H. McCollough, R. W. Viggiano, D. E. Midthun, E. F. Patz, J. R. Muhm, and A. L. Weaver. “Lung nodules: dual-kilovolt peak analysis with CT--multicenter study.” Radiology 214, no. 1 (January 2000): 81–85. https://doi.org/10.1148/radiology.214.1.r00ja2681.Full Text Link to Item
-
Swensen, S. J., R. W. Viggiano, D. E. Midthun, N. L. Müller, A. Sherrick, K. Yamashita, D. P. Naidich, et al. “Lung nodule enhancement at CT: multicenter study.” Radiology 214, no. 1 (January 2000): 73–80. https://doi.org/10.1148/radiology.214.1.r00ja1473.Full Text Link to Item
-
Patz, E. F. “PET imaging in the thorax.” Annual International Conference of the Ieee Engineering in Medicine and Biology Proceedings 2 (December 1, 1999): 1329.
-
Patz, E., H. McAdams, J. Erasmus, P. Goodman, D. Culhane, R. Gilkeson, and J. Herndon. “Sclerotherapy for malignant pleural effusions.” Pneumologie 53, no. 2 (December 1, 1999): 112.
-
Patz, E., H. Me Adams, J. Erasmus, P. Goodman, D. Culhane, R. Gilkeson, and J. Herndon. “Sclerotherapy for malignant pleural effusions.” Pneumologie 53, no. 1 (December 1, 1999): 44.
-
Erasmus, J. J., and E. F. Patz. “Positron emission tomography imaging in the thorax.” Clin Chest Med 20, no. 4 (December 1999): 715–24. https://doi.org/10.1016/s0272-5231(05)70250-1.Full Text Link to Item
-
Hara, M., H. P. McAdams, J. J. Vredenburgh, J. E. Herndon, and E. F. Patz. “Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer.” Ajr Am J Roentgenol 173, no. 5 (November 1999): 1341–44. https://doi.org/10.2214/ajr.173.5.10541115.Full Text Link to Item
-
Erasmus, J. J., H. P. McAdams, and E. F. Patz. “Non-small cell lung cancer: FDG-PET imaging.” J Thorac Imaging 14, no. 4 (October 1999): 247–56. https://doi.org/10.1097/00005382-199910000-00004.Full Text Link to Item
-
Patz, E. F. “Imaging lung cancer.” Semin Oncol 26, no. 5 Suppl 15 (October 1999): 21–26.Link to Item
-
Patz, E. F. “Imaging lung cancer.” Seminars in Oncology 26, no. 5 (October 1, 1999): 21–26.Link to Item
-
Marom, E. M., E. F. Patz, and S. J. Swensen. “Radiologic findings of bronchogenic carcinoma with pulmonary metastases at presentation.” Clin Radiol 54, no. 10 (October 1999): 665–68. https://doi.org/10.1016/s0009-9260(99)91088-7.Full Text Link to Item
-
Marom, E. M., H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz. “Staging non-small cell lung cancer with whole-body PET.” Radiology 212, no. 3 (September 1999): 803–9. https://doi.org/10.1148/radiology.212.3.r99se21803.Full Text Link to Item
-
Connolly, J. E., J. J. Erasmus, and E. F. Patz. “Thoracic manifestations of breast carcinoma: metastatic disease and complications of treatment.” Clin Radiol 54, no. 8 (August 1999): 487–94. https://doi.org/10.1016/s0009-9260(99)90844-9.Full Text Link to Item
-
Patz, E. F., and J. J. Erasmus. “Positron emission tomography imaging in lung cancer.” Clin Lung Cancer 1, no. 1 (August 1999): 42–48. https://doi.org/10.3816/clc.1999.n.002.Full Text Link to Item
-
Erasmus, J. J., and E. F. Patz. “Treatment of malignant pleural effusions.” Curr Opin Pulm Med 5, no. 4 (July 1999): 250–55. https://doi.org/10.1097/00063198-199907000-00013.Full Text Link to Item
-
Patz, E. F., J. J. Erasmus, H. P. McAdams, J. E. Connolly, E. M. Marom, P. C. Goodman, R. A. Leder, M. T. Keogan, and J. E. Herndon. “Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax.” Radiology 212, no. 1 (July 1999): 56–60. https://doi.org/10.1148/radiology.212.1.r99jl1956.Full Text Link to Item
-
Patz, E. F. “Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease - Commentary.” Journal of Thoracic and Cardiovascular Surgery 117, no. 4 (April 1, 1999): 726–27.Link to Item
-
Graeber, G. M., N. C. Gupta, and G. F. Murray. “Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.” J Thorac Cardiovasc Surg 117, no. 4 (April 1999): 719–27. https://doi.org/10.1016/S0022-5223(99)70292-8.Full Text Link to Item
-
Munley, M. T., L. B. Marks, C. Scarfone, G. S. Sibley, E. F. Patz, T. G. Turkington, R. J. Jaszczak, D. R. Gilland, M. S. Anscher, and R. E. Coleman. “Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.” Lung Cancer 23, no. 2 (February 1999): 105–14. https://doi.org/10.1016/s0169-5002(99)00005-7.Full Text Link to Item
-
Collier, T. L., R. N. Waterhouse, P. W. Schiller, and J. Patz. “Radiosynthesis and in-vivo evaluation of the pseudopeptide δ-opioid antagonist [125I]-ITIPP(Ψ).” Journal of Labelled Compounds and Radiopharmaceuticals 42, no. SUPPL. 1 (January 1, 1999).
-
Erasmus, J. J., H. P. McAdams, and E. F. Patz. “Non-small cell lung cancer: FDG-PET imaging.” Journal of Thoracic Imaging 14, no. 4 (January 1, 1999): 247–56. https://doi.org/10.1080/00005382-199910000-00004.Full Text
-
Patz, E. F. “Lung cancer, Part I: From the guest editor.” Journal of Thoracic Imaging 14, no. 4 I (January 1, 1999): 227. https://doi.org/10.1097/00005382-199910000-00001.Full Text
-
Patz, J. “Imaging lung cancer.” Seminars in Oncology 26, no. 5 SUPPL. 15 (January 1, 1999): 21–26.
-
Erasmus, J. J., H. P. McAdams, M. A. Farrell, and E. F. Patz. “Pulmonary nontuberculous mycobacterial infection: radiologic manifestations.” Radiographics 19, no. 6 (1999): 1487–1505. https://doi.org/10.1148/radiographics.19.6.g99no101487.Full Text Link to Item
-
Marom, E. M., E. F. Patz, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon. “Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.” Radiology 210, no. 1 (January 1999): 277–81. https://doi.org/10.1148/radiology.210.1.r99dc04277.Full Text Link to Item
-
Lowe, V. J., J. W. Fletcher, L. Gobar, M. Lawson, P. Kirchner, P. Valk, J. Karis, et al. “Prospective investigation of positron emission tomography in lung nodules.” Pneumologie 52, no. 7 (December 1, 1998): 432.
-
McAdams, H. P., S. M. Palmer, J. J. Erasmus, E. F. Patz, J. E. Connolly, P. C. Goodman, D. M. Delong, and V. F. Tapson. “Bronchial anastomotic complications in lung transplant recipients: virtual bronchoscopy for noninvasive assessment.” Radiology 209, no. 3 (December 1998): 689–95. https://doi.org/10.1148/radiology.209.3.9844660.Full Text Link to Item
-
Marom, E. M., E. F. Patz, J. J. Erasmus, H. P. McAdams, E. Coleman, and P. C. Goodman. “Whole body positron emission tomography for staging bronchogenic carcinoma.” Radiology 209P (November 1, 1998): 376–376.Link to Item
-
Patz, E. F., J. J. Erasmus, H. P. McAdams, E. M. Marom, J. C. Connolly, and P. C. Goodman. “Thoracic CT for staging bronchogenic carcinoma: Does IV contrast enhancement change stage and management?” Radiology 209P (November 1, 1998): 376–376.Link to Item
-
Waterhouse, R. N., M. J. Campa, J. Park, and E. F. Patz. “Radioiodinated (+)-4-[(αR)-α-[(2S, 5R)-4-(iodopropen-2-yl)-2,5- dimethyl-1-piperazinyl]-3-hydroxybenzyl]-N, N-diethylbenzamide: A potential ligand for in vitro and in vivo investigations of δ-opioid receptors.” Journal of Labelled Compounds and Radiopharmaceuticals 41, no. 9 (September 1, 1998): 801–10. https://doi.org/10.1002/(SICI)1099-1344(1998090)41:9<801::AID-JLCR130>3.0.CO;2-C.Full Text
-
Ahuja, V., R. E. Coleman, J. Herndon, and E. F. Patz. “The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.” Cancer 83, no. 5 (September 1, 1998): 918–24.Link to Item
-
Schreiber, G., M. J. Campa, S. Prabhakar, K. O’Briant, G. Bepler, and E. F. Patz. “Molecular characterization of the human δ opioid receptor in lung cancer.” Anticancer Research 18, no. 3 A (May 1, 1998): 1787–92.
-
Waterhouse, R. N., M. F. Smith, K. L. Greer, T. L. Collier, S. Eberl, J. Towson, A. Birrell, et al. “Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent.” Journal of Nuclear Medicine 39, no. 5 (May 1, 1998): 227P-227P.Link to Item
-
Assi, Z., J. L. Caruso, J. Herndon, and E. F. Patz. “Cytologically proved malignant pleural effusions: distribution of transudates and exudates.” Chest 113, no. 5 (May 1998): 1302–4. https://doi.org/10.1378/chest.113.5.1302.Full Text Link to Item
-
Erasmus, J. J., H. P. McAdams, E. F. Patz, R. E. Coleman, V. Ahuja, and P. C. Goodman. “Evaluation of primary pulmonary carcinoid tumors using FDG PET.” Ajr Am J Roentgenol 170, no. 5 (May 1998): 1369–73. https://doi.org/10.2214/ajr.170.5.9574618.Full Text Link to Item
-
Patz, E. F., H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. C. Gilkeson, and J. Herndon. “Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage.” Chest 113, no. 5 (May 1998): 1305–11. https://doi.org/10.1378/chest.113.5.1305.Full Text Link to Item
-
Patz, E. F., P. C. Goodman, and J. J. Erasmus. “Percutaneous drainage of pleural collections.” J Thorac Imaging 13, no. 2 (April 1998): 83–92. https://doi.org/10.1097/00005382-199804000-00003.Full Text Link to Item
-
Lowe, V. J., J. W. Fletcher, L. Gobar, M. Lawson, P. Kirchner, P. Valk, J. Karis, et al. “Prospective investigation of positron emission tomography in lung nodules.” J Clin Oncol 16, no. 3 (March 1998): 1075–84. https://doi.org/10.1200/JCO.1998.16.3.1075.Full Text Link to Item
-
Erasmus, J. J., and E. F. P. Jr. “Imaging of the solitary pulmonary nodule.” Seminars in Respiratory and Critical Care Medicine 19, no. 5 (1998): 483–91.
-
Erasmus, J. J., and E. F. Patz. “Imaging of the solitary pulmonary nodule.” Seminars in Respiratory and Critical Care Medicine 19, no. 5 (January 1, 1998): 483–91. https://doi.org/10.1055/s-2007-1009424.Full Text
-
Patz, E. F. “The society of thoracic radiology research and education foundation seed grant guidelines and submission procedures.” Journal of Thoracic Imaging 13, no. 4 (January 1, 1998): 219. https://doi.org/10.1080/00005382-199810000-00001.Full Text
-
Patz, E. F. “Malignant pleural effusions: Recent advances and ambulatory sclerotherapy.” Chest 113, no. 1 SUPPL. (January 1, 1998): 74S-77S.
-
Boiselle, P. M., E. F. Patz, D. J. Vining, R. Weissleder, J. A. Shepard, and T. C. McLoud. “Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.” Radiographics 18, no. 5 (1998): 1061–69. https://doi.org/10.1148/radiographics.18.5.9747607.Full Text Link to Item
-
Erasmus, J. J., H. P. McAdams, E. F. Patz, P. C. Goodman, and R. E. Coleman. “Thoracic FDG PET: state of the art.” Radiographics 18, no. 1 (1998): 5–20. https://doi.org/10.1148/radiographics.18.1.9460106.Full Text Link to Item
-
Gilkeson, R. C., E. F. Patz, D. Culhane, H. P. McAdams, and J. M. Provenzale. “Thoracic imaging features of patients with antiphospholipid antibodies.” J Comput Assist Tomogr 22, no. 2 (1998): 241–44. https://doi.org/10.1097/00004728-199803000-00015.Full Text Link to Item
-
McAdams, H. P., J. J. Erasums, E. F. Patz, P. C. Goodman, and R. E. Coleman. “Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET.” J Comput Assist Tomogr 22, no. 4 (1998): 601–4. https://doi.org/10.1097/00004728-199807000-00017.Full Text Link to Item
-
Patz, E. F. “Malignant pleural effusions: recent advances and ambulatory sclerotherapy.” Chest 113, no. 1 Suppl (January 1998): 74S-77S. https://doi.org/10.1378/chest.113.1_supplement.74s.Full Text Link to Item
-
Schreiber, G., M. J. Campa, S. Prabhakar, K. O’Briant, G. Bepler, and E. F. Patz. “Molecular characterization of the human delta opioid receptor in lung cancer.” Anticancer Res 18, no. 3A (1998): 1787–92.Link to Item
-
Smith, D. N., K. Shaffer, and E. F. Patz. “Imaging features of nonmyxomatous primary neoplasms of the heart and pericardium.” Clin Imaging 22, no. 1 (1998): 15–22. https://doi.org/10.1016/s0899-7071(97)00070-3.Full Text Link to Item
-
Murray, J. G., E. F. Patz, J. J. Erasmus, and R. C. Gilkeson. “CT appearance of the pleural space after talc pleurodesis.” Ajr Am J Roentgenol 169, no. 1 (July 1997): 89–91. https://doi.org/10.2214/ajr.169.1.9207506.Full Text Link to Item
-
McAdams, H. P., M. Rosado de Christenson, D. C. Strollo, and E. F. Patz. “Pulmonary mucormycosis: radiologic findings in 32 cases.” Ajr Am J Roentgenol 168, no. 6 (June 1997): 1541–48. https://doi.org/10.2214/ajr.168.6.9168721.Full Text Link to Item
-
Erasmus, J. J., E. F. Patz, H. P. McAdams, J. G. Murray, J. Herndon, R. E. Coleman, and P. C. Goodman. “Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.” Ajr Am J Roentgenol 168, no. 5 (May 1997): 1357–60. https://doi.org/10.2214/ajr.168.5.9129444.Full Text Link to Item
-
Lowe, V. J., F. G. Duhaylongsod, E. F. Patz, D. M. Delong, J. M. Hoffman, W. G. Wolfe, and R. E. Coleman. “Pulmonary abnormalities and PET data analysis: a retrospective study.” Radiology 202, no. 2 (February 1997): 435–39. https://doi.org/10.1148/radiology.202.2.9015070.Full Text Link to Item
-
Davey, N. C., I. C. Davey, V. G. McDermott, T. P. Smith, E. F. Patz, and J. J. Erasmus. “State-of-the-art imaging of pulmonary embolic disease.” Radiology 201 (November 1, 1996): 373–373.Link to Item
-
Erasmus, J. J., H. P. McAdams, E. F. Patz, P. C. Goodman, and R. E. Coleman. “Thoracic FDG PET: State of the art.” Radiology 201 (November 1, 1996): 332–332.Link to Item
-
Floyd, C. E., E. F. Patz, J. Y. Lo, N. F. Vittitoe, and L. E. Stambaugh. “Diffuse nodular lung disease on chest radiographs: a pilot study of characterization by fractal dimension.” Ajr Am J Roentgenol 167, no. 5 (November 1996): 1185–87. https://doi.org/10.2214/ajr.167.5.8911177.Full Text Link to Item
-
Swensen, S. J., J. H. Tashjian, J. L. Myers, C. E. Engeler, E. F. Patz, W. D. Edwards, and W. W. Douglas. “Pulmonary venoocclusive disease: CT findings in eight patients.” Ajr Am J Roentgenol 167, no. 4 (October 1996): 937–40. https://doi.org/10.2214/ajr.167.4.8819387.Full Text Link to Item
-
Campa, M. J., R. W. McNutt, J. A. Hill, E. F. Patz, and K. J. Chang. “Binding of [3H](+)-BW373U86 to delta-opioid receptors in rat brain membranes.” Eur J Pharmacol 310, no. 2–3 (August 29, 1996): 263–67. https://doi.org/10.1016/0014-2999(96)00483-9.Full Text Link to Item
-
Hebert, M. E., V. J. Lowe, J. M. Hoffman, E. F. Patz, and M. S. Anscher. “Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.” Am J Clin Oncol 19, no. 4 (August 1996): 416–21. https://doi.org/10.1097/00000421-199608000-00020.Full Text Link to Item
-
Kaiser, L. R., E. F. Patz, and P. G. Tuteur. “A rational approach to the solitary pulmonary nodule.” Patient Care 30, no. 12 (July 15, 1996): 183–98.
-
Murray, J. G., H. P. McAdams, J. J. Erasmus, E. F. Patz, and V. Tapson. “Complications of lung transplantation: radiologic findings.” Ajr Am J Roentgenol 166, no. 6 (June 1996): 1405–11. https://doi.org/10.2214/ajr.166.6.8633454.Full Text Link to Item
-
Chang, Y. C., E. F. Patz, and P. C. Goodman. “Pneumothorax after small-bore catheter placement for malignant pleural effusions.” Ajr Am J Roentgenol 166, no. 5 (May 1996): 1049–51. https://doi.org/10.2214/ajr.166.5.8615239.Full Text Link to Item
-
Campa, M. J., G. Schreiber, G. Bepler, M. J. Bishop, R. W. McNutt, K. J. Chang, and E. F. Patz. “Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.” Cancer Res 56, no. 7 (April 1, 1996): 1695–1701.Link to Item
-
Patz, E. F., H. P. McAdams, P. C. Goodman, S. Blackwell, and J. Crawford. “Ambulatory sclerotherapy for malignant pleural effusions.” Radiology 199, no. 1 (April 1996): 133–35. https://doi.org/10.1148/radiology.199.1.8633136.Full Text Link to Item
-
Chang, Y. C., E. F. Patz, P. C. Goodman, and C. B. Granger. “Significance of hemoptysis following thrombolytic therapy for acute myocardial infarction.” Chest 109, no. 3 (March 1996): 727–29. https://doi.org/10.1378/chest.109.3.727.Full Text Link to Item
-
Patz, E. F., V. W. Rusch, and R. Heelan. “The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.” Ajr Am J Roentgenol 166, no. 2 (February 1996): 323–27. https://doi.org/10.2214/ajr.166.2.8553940.Full Text Link to Item
-
Erasmus, J. J., H. P. McAdams, E. F. Patz, J. G. Murray, and N. B. Pinkard. “Calcifying fibrous pseudotumor of pleura: radiologic features in three cases.” J Comput Assist Tomogr 20, no. 5 (1996): 763–65. https://doi.org/10.1097/00004728-199609000-00014.Full Text Link to Item
-
Kang, E. Y., E. F. Patz, and N. L. Müller. “Cytomegalovirus pneumonia in transplant patients: CT findings.” J Comput Assist Tomogr 20, no. 2 (1996): 295–99. https://doi.org/10.1097/00004728-199603000-00024.Full Text Link to Item
-
Layfield, L. J., A. Coogan, W. W. Johnston, and E. F. Patz. “Transthoracic fine needle aspiration biopsy. Sensitivity in relation to guidance technique and lesion size and location.” Acta Cytol 40, no. 4 (1996): 687–90. https://doi.org/10.1159/000333940.Full Text Link to Item
-
Sostman, H. D., D. T. Layish, V. F. Tapson, C. E. Spritzer, D. M. DeLong, P. Trotter, J. R. MacFall, et al. “Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism.” J Magn Reson Imaging 6, no. 2 (1996): 275–81. https://doi.org/10.1002/jmri.1880060203.Full Text Link to Item
-
Patz, E. F., V. J. Lowe, P. C. Goodman, and J. Herndon. “Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.” Chest 108, no. 6 (December 1995): 1617–21. https://doi.org/10.1378/chest.108.6.1617.Full Text Link to Item
-
HEELAN, R. T., E. F. PATZ, and V. W. RUSCH. “NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURAL MESOTHELIOMA.” Radiology 197 (November 1, 1995): 302–302.Link to Item
-
MCADAMS, H. P., E. F. PATZ, P. C. GOODMAN, and J. CRAWFORD. “AMBULATORY SCLEROTHERAPY FOR TREATMENT OF MALIGNANT PLEURAL EFFUSION.” Radiology 197 (November 1, 1995): 163–163.Link to Item
-
SOSTMAN, H. D., D. T. LAYISH, C. E. SPRITZER, P. C. GOODMAN, E. F. PATZ, and J. R. MACFALL. “MR-IMAGING AND CT FOR DETECTING PULMONARY-EMBOLISM AND VENOUS THROMBOEMBOLISM.” Radiology 197 (November 1, 1995): 303–303.Link to Item
-
Duhaylongsod, F. G., V. J. Lowe, E. F. Patz, A. L. Vaughn, R. E. Coleman, and W. G. Wolfe. “Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.” Ann Thorac Surg 60, no. 5 (November 1995): 1348–52. https://doi.org/10.1016/0003-4975(95)00754-9.Full Text Link to Item
-
Rusch, V. W. “A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.” Chest 108, no. 4 (October 1995): 1122–28. https://doi.org/10.1378/chest.108.4.1122.Full Text Link to Item
-
Duhaylongsod, F. G., V. J. Lowe, E. F. Patz, A. L. Vaughn, R. E. Coleman, and W. G. Wolfe. “Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).” J Thorac Cardiovasc Surg 110, no. 1 (July 1995): 130–39. https://doi.org/10.1016/S0022-5223(05)80018-2.Full Text Link to Item
-
Patz, E. F., S. J. Swensen, and J. Erasmus. “Pulmonary manifestations of nontuberculous Mycobacterium.” Radiol Clin North Am 33, no. 4 (July 1995): 719–29.Link to Item
-
LEE, V. S., E. F. PATZ, and J. T. T. CHEN. “ATYPICAL AND UNUSUAL CALCIFICATIONS OF THE HEART AND GREAT-VESSELS - IMAGING FINDINGS (VOL 163, PG 1349, 1994).” American Journal of Roentgenology 164, no. 4 (April 1, 1995): 1002–1002.Link to Item
-
Patz, E. F., J. Fidler, M. Knelson, S. Paine, and P. Goodman. “Significance of percutaneous needle biopsy in patients with multiple pulmonary nodules and a single known primary malignancy.” Chest 107, no. 3 (March 1995): 601–4. https://doi.org/10.1378/chest.107.3.601.Full Text Link to Item
-
Seaton, K. G., E. F. Patz, and P. C. Goodman. “Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy.” Ajr Am J Roentgenol 164, no. 3 (March 1995): 589–91. https://doi.org/10.2214/ajr.164.3.7532350.Full Text Link to Item
-
Patz, E. F., N. L. Müller, S. J. Swensen, and L. G. Dodd. “Congenital cystic adenomatoid malformation in adults: CT findings.” J Comput Assist Tomogr 19, no. 3 (1995): 361–64. https://doi.org/10.1097/00004728-199505000-00004.Full Text Link to Item
-
Woodard, P. K., H. D. Sostman, J. R. MacFall, D. M. DeLong, J. W. McDonald, T. K. Foo, E. F. Patz, P. C. Goodman, and C. E. Spritzer. “Detection of pulmonary embolism: comparison of contrast-enhanced spiral CT and time-of-flight MR techniques.” J Thorac Imaging 10, no. 1 (1995): 59–72.Link to Item
-
Lee, V. S., E. F. Patz, and J. T. Chen. “Atypical and unusual calcifications of the heart and great vessels: imaging findings.” Ajr Am J Roentgenol 163, no. 6 (December 1994): 1349–55. https://doi.org/10.2214/ajr.163.6.7992726.Full Text Link to Item
-
Lowe, V. J., J. M. Hoffman, D. M. DeLong, E. F. Patz, and R. E. Coleman. “Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.” J Nucl Med 35, no. 11 (November 1994): 1771–76.Link to Item
-
Patz, E. F., and P. C. Goodman. “Positron emission tomography imaging of the thorax.” Radiol Clin North Am 32, no. 4 (July 1994): 811–23.Link to Item
-
LOWE, V. J., D. M. DELONG, J. M. HOFFMAN, E. F. PATZ, and R. E. COLEMAN. “DYNAMIC FDG-PET IMAGING OF FOCAL PULMONARY ABNORMALITIES TO IDENTIFY OPTIMUM TIME FOR IMAGING.” Journal of Nuclear Medicine 35, no. 5 (May 1, 1994): P225–P225.Link to Item
-
LOWE, V. J., J. M. HOFFMAN, D. M. DELONG, E. F. PATZ, and R. E. COLEMAN. “ROC CURVE AND LOGISTIC-REGRESSION ANALYSIS OF VISUAL AND SEMIQUANTITATIVE FDG PET DATA IN THE EVALUATION OF FOCAL PULMONARY ABNORMALITIES.” Journal of Nuclear Medicine 35, no. 5 (May 1, 1994): P227–P227.Link to Item
-
Chai, J. L., and E. F. Patz. “CT of the lung: patterns of calcification and other high-attenuation abnormalities.” Ajr Am J Roentgenol 162, no. 5 (May 1994): 1063–66. https://doi.org/10.2214/ajr.162.5.8165982.Full Text Link to Item
-
Patz, E. F., V. J. Lowe, J. M. Hoffman, S. S. Paine, L. K. Harris, and P. C. Goodman. “Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.” Radiology 191, no. 2 (May 1994): 379–82. https://doi.org/10.1148/radiology.191.2.8153309.Full Text Link to Item
-
Shaffer, K., M. L. Rosado-de-Christenson, E. F. Patz, S. Young, and C. F. Farver. “Thoracic lymphangioma in adults: CT and MR imaging features.” Ajr Am J Roentgenol 162, no. 2 (February 1994): 283–89. https://doi.org/10.2214/ajr.162.2.8310910.Full Text Link to Item
-
PATZ, EF Jr. “Persistent or recurrent bronchogenic carcinoma : detection with PET and 2-[F-18]-2-deoxy-D-glucose.” Radiology 191 (1994): 379–82.
-
Patz, E. F., W. P. Peters, and P. C. Goodman. “Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases.” J Thorac Imaging 9, no. 2 (1994): 129–34. https://doi.org/10.1097/00005382-199421000-00017.Full Text Link to Item
-
Fidler, J. L., E. F. Patz, and C. E. Ravin. “Cardiopulmonary complications of pregnancy: radiographic findings.” Ajr Am J Roentgenol 161, no. 5 (November 1993): 937–42. https://doi.org/10.2214/ajr.161.5.8273629.Full Text Link to Item
-
Patz, E. F., V. J. Lowe, J. M. Hoffman, S. S. Paine, P. Burrowes, R. E. Coleman, and P. C. Goodman. “Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.” Radiology 188, no. 2 (August 1993): 487–90. https://doi.org/10.1148/radiology.188.2.8327702.Full Text Link to Item
-
LOWE, V. J., J. M. HOFFMAN, E. F. PATZ, S. PAINE, P. BURROWS, and R. E. COLEMAN. “DIFFERENTIATION OF BENIGN AND MALIGNANT PULMONARY OPACITIES WITH FDG-PET.” Journal of Nuclear Medicine 34, no. 5 (May 1, 1993): P21–P21.Link to Item
-
Dobbins, J. T., J. J. Rice, P. C. Goodman, E. F. Patz, and C. E. Ravin. “Variable compensation chest radiography performed with a computed radiography system: design considerations and initial clinical experience.” Radiology 187, no. 1 (April 1993): 55–63. https://doi.org/10.1148/radiology.187.1.8451437.Full Text Link to Item
-
PATZ, EF Jr. “Focal pulmonary abnormalities : evaluation with F-18 fluorodeoxyglucose PET scanning.” Radiology 188 (1993): 487–90.
-
Patz, E. F., P. Stark, K. Shaffer, and R. D. Pugatch. “Identification of internal mammary lymph nodes: value of the frontal chest radiograph.” J Thorac Imaging 8, no. 1 (1993): 81–84.Link to Item
-
Patz, E. F., K. Shaffer, D. R. Piwnica-Worms, M. Jochelson, M. Sarin, D. J. Sugarbaker, and R. D. Pugatch. “Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.” Ajr Am J Roentgenol 159, no. 5 (November 1992): 961–66. https://doi.org/10.2214/ajr.159.5.1414807.Full Text Link to Item
-
Patz, E. F., and P. C. Goodman. “Pulmonary cryptococcosis.” J Thorac Imaging 7, no. 4 (September 1992): 51–55. https://doi.org/10.1097/00005382-199209000-00008.Full Text Link to Item
-
PATZ, E. F. “Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.” Ajr 159 (1992): 961–66.
-
Woodard, P. K., E. F. Patz, and H. D. Sostman. “Pseudoaneurysms at aortic cannulation site after coronary artery bypass graft: MR findings.” J Comput Assist Tomogr 16, no. 6 (1992): 883–87. https://doi.org/10.1097/00004728-199211000-00010.Full Text Link to Item
-
Patz, E. F. “Radiopacity of glass.” Ajr Am J Roentgenol 150, no. 2 (February 1988): 472. https://doi.org/10.2214/ajr.150.2.472-a.Full Text Link to Item
-
-
Book Sections
-
Christensen, Jared, Edward Patz, and Jeremy Erasmus. “Catheter Drainage of Intrathoracic Collections.” In Handbook of Interventional Radiologic Procedures. LWW, 2016.
-
-
Other Articles
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S4 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274972.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S2 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274978.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S3 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274975.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Table S1 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274966.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S1 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274981.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S3 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274975.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Table S2 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274963.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Table S2 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274963.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S5 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274969.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S1 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274981.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S5 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274969.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Data from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.c.6674760.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Data from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.c.6674760.v1.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S4 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274972.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Figure S2 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274978.Full Text
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Table S1 from Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103,” June 1, 2023. https://doi.org/10.1158/1535-7163.23274966.Full Text
-
-
Conference Papers
-
Dinan, M. A., L. H. Curtis, W. R. Carpenter, A. K. Biddle, A. P. Abernethy, E. F. Patz, K. A. Schulman, and M. Weinberger. “Changes in Radiation Therapy, Surgery, and Costs for Treatment of Non-Small Cell Lung Cancer After the Adoption of Positron Emission Tomography: 1998-2005.” In International Journal of Radiation Oncology*Biology*Physics, 87:S41–42. Elsevier BV, 2013. https://doi.org/10.1016/j.ijrobp.2013.06.110.Full Text
-
Berghmans, T., M. Paesmans, M. Dusart, C. Hossein-Foucher, C. Castaigne, C. Mascaux, M. Roelandts, J. J. Lafitte, E. F. Patz, and J. P. Sculier. “6524 POSTER Primary tumour standardized uptake value (SUV max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Staging Project.” In European Journal of Cancer Supplements, 5:364–65. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)71352-6.Full Text
-
Gandara, David R., Denise Aberle, Derick Lau, James Jett, Tim Akhurst, James Mulshine, Christine Berg, and Edward F. Patz. “Radiographic Imaging of Bronchioloalveolar Carcinoma: Screening, Patterns of Presentation and Response Assessment.” In Journal of Thoracic Oncology, 1:S20–26. Elsevier BV, 2006. https://doi.org/10.1097/01243894-200611001-00005.Full Text
-
Pratapa, Pallavi N., Edward F. Patz, and Alexander J. Hartemink. “Finding diagnostic biomarkers in proteomic spectra.” In Pac Symp Biocomput, 279–90, 2006.Link to Item
-
Lin, S. M., M. J. Campa, M. Z. Wang, B. Howard, M. C. Fitzgerald, and E. F. Patz. “Use of mixture models in MALDI-TOF proteomic data for peak registration.” In Proceedings of the 7th Joint Conference on Information Sciences, edited by S. H. Chen, H. D. Cheng, D. K. Y. Chiu, S. Das, R. Duro, E. E. Kerre, H. V. Leong, et al., 873–78. ASSOC INTELLIGENT MACHINERY, 2003.Link to Item
-
Aloia, T., H. P. McAdams, G. Bepler, D. H. Harpole, P. C. Goodman, and E. F. Patz. “Integration of peripheral blood biomarkers with CT to differentiate benign from malignant pulmonary opacities.” In Radiology, 217:469–469. RADIOLOGICAL SOC NORTH AMER, 2000.Link to Item
-
-
Preprints
-
Bushey, Ryan T., Ruchi Saxena, Michael J. Campa, Elizabeth B. Gottlin, You-Wen He, and Edward F. Patz. “Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.” Research Square Platform LLC, November 3, 2022. https://doi.org/10.21203/rs.3.rs-2234932/v1.Full Text
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.